UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 106

Sortiert nach

Drug tolerability and reasons for discontinuation of seven biologics in 4466 treatment courses of rheumatoid arthritis-the ANSWER cohort study

Arthritis research & therapy, 2019-04, Vol.21 (1), p.91-10, Article 91

2019

Link zum Volltext

Verfügbarkeit prüfen

Management and treatment outcomes of rheumatoid arthritis in the era of biologic and targeted synthetic therapies: evaluation of 10-year data from the KURAMA cohort

Arthritis research & therapy, 2024-01, Vol.26 (1), p.16-16, Article 16

2024

Link zum Volltext

Verfügbarkeit prüfen

Monocyte-derived transcriptomes explain the ineffectiveness of abatacept in rheumatoid arthritis

Arthritis research & therapy, 2024-01, Vol.26 (1), p.1-1, Article 1

2024

Link zum Volltext

Verfügbarkeit prüfen

Drug retention of 7 biologics and tofacitinib in biologics-naïve and biologics-switched patients with rheumatoid arthritis: the ANSWER cohort study

Arthritis research & therapy, 2020-06, Vol.22 (1), p.1-11, Article 142

2020

Link zum Volltext

Verfügbarkeit prüfen

Comparison of the drug retention and reasons for discontinuation of tumor necrosis factor inhibitors and interleukin-6 inhibitors in Japanese patients with elderly-onset rheumatoid arthritis-the ANSWER cohort study

Arthritis research & therapy, 2021-04, Vol.23 (1), p.116-9, Article 116

2021

Link zum Volltext

Verfügbarkeit prüfen

Identification of anti-citrullinated osteopontin antibodies and increased inflammatory response by enhancement of osteopontin binding to fibroblast-like synoviocytes in rheumatoid arthritis

Arthritis research & therapy, 2023-02, Vol.25 (1), p.25-25, Article 25

2023

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of personalized exercise program on physical function in elderly patients with rheumatoid arthritis at high risk for sarcopenia: study protocol for a randomized controlled trial

BMC musculoskeletal disorders, 2023-04, Vol.24 (1), p.280-280, Article 280

2023

Link zum Volltext

Verfügbarkeit prüfen

N-terminus of Etanercept is Proteolytically Processed by Dipeptidyl Peptidase-4

Pharmaceutical research, 2022-10, Vol.39 (10), p.2541-2554

2022

Link zum Volltext

Verfügbarkeit prüfen

Drug retention of sarilumab, baricitinib, and tofacitinib in patients with rheumatoid arthritis: the ANSWER cohort study

Clinical rheumatology, 2021-07, Vol.40 (7), p.2673-2680

2021

Link zum Volltext

Verfügbarkeit prüfen

Comparison of efficacy between anti-IL-6 receptor antibody and other biological disease-modifying antirheumatic drugs in the patients with rheumatoid arthritis who have knee joint involvement: the ANSWER cohort, retrospective study

Rheumatology international, 2021-07, Vol.41 (7), p.1233-1241

2021

Link zum Volltext

Verfügbarkeit prüfen

Drug retention of secondary biologics or JAK inhibitors after tocilizumab or abatacept failure as first biologics in patients with rheumatoid arthritis -the ANSWER cohort study

Clinical rheumatology, 2020-09, Vol.39 (9), p.2563-2572

2020

Link zum Volltext

Verfügbarkeit prüfen

The real-world effectiveness of anti-RANKL antibody denosumab on the clinical fracture prevention in patients with rheumatoid arthritis: The ANSWER cohort study

Modern rheumatology, 2022-07, Vol.32 (4), p.834-838

2022

Link zum Volltext

Verfügbarkeit prüfen

Comparison of the efficacy and safety of biologic agents between elderly-onset and young-onset RA patients: the ANSWER cohort study

Rheumatology international, 2020-12, Vol.40 (12), p.1987-1995

2020

Link zum Volltext

Verfügbarkeit prüfen

Large vessel vasculopathy in a patient with systemic lupus erythematosus: a case report

Journal of medical case reports, 2019-06, Vol.13 (1), p.189-189, Article 189

2019

Link zum Volltext

Verfügbarkeit prüfen

Correction to: Drug tolerability and reasons for discontinuation of seven biologics in 4466 treatment courses of rheumatoid arthritis-the ANSWER cohort study

Arthritis research & therapy, 2019-05, Vol.21 (1), p.114-114, Article 114

2019

Link zum Volltext

Verfügbarkeit prüfen

Late-onset rheumatoid arthritis registry study, LORIS study: study protocol and design

BMC rheumatology, 2022-12, Vol.6 (1), p.90-90, Article 90

2022

Link zum Volltext

Verfügbarkeit prüfen

Mycophenolate mofetil versus intravenous cyclophosphamide for induction treatment of proliferative lupus nephritis in a Japanese population: a retrospective study

Modern rheumatology, 2013-01, Vol.23 (1), p.89-96

2013

Link zum Volltext

Verfügbarkeit prüfen

Comparative effectiveness of trimethoprim-sulfamethoxazole versus atovaquone for the prophylaxis of pneumocystis pneumonia in patients with connective tissue diseases receiving prolonged high-dose glucocorticoids

Rheumatology international, 2022-08, Vol.42 (8), p.1403-1409

2022

Link zum Volltext

Verfügbarkeit prüfen

Mycophenolate mofetil versus intravenous cyclophosphamide for induction treatment of proliferative lupus nephritis in a Japanese population: a retrospective study

Modern rheumatology, 2013-01, Vol.23 (1), p.89-96

2013

Link zum Volltext

Verfügbarkeit prüfen

Comparison of safety and effectiveness between etanercept biosimilar LBEC0101 and reference in patients with rheumatoid arthritis in real-world data using the KURAMA cohort

Modern rheumatology, 2024-03

2024

Link zum Volltext

Verfügbarkeit prüfen

Pathogenicity of IgG-Fc desialylation and its association with Th17 cells in an animal model of systemic lupus erythematosus

Modern rheumatology, 2024-03, Vol.34 (3), p.523-529

2024

Link zum Volltext

Verfügbarkeit prüfen

Enteric Toll-like receptor 7 stimulation causes acute exacerbation in lupus-susceptible mice

Clinical rheumatology, 2023-04, Vol.42 (4), p.1185-1194

2023

Link zum Volltext

Verfügbarkeit prüfen

High plasma homocysteine level is associated with increased prevalence of the non-remission state in rheumatoid arthritis: Findings from the KURAMA cohort

Modern rheumatology, 2023-08, Vol.33 (5), p.911-917

2023

Link zum Volltext

Verfügbarkeit prüfen

Factors associated with osteoporosis and fractures in patients with systemic lupus erythematosus: Kyoto Lupus Cohort

Modern rheumatology, 2023-12, Vol.34 (1), p.113-121

2023

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 106

Suche als RSS-Feed

Aktive Filter

KollektionSpringer journals

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(100)
Mit Volltextzugriff
(96)

Publikationsform

Artikel
(106)

Sprache

Englisch
(106)
Japanisch
(26)

Erscheinungsjahr

n.n

Thema

Science & Technology
(83)
Life Sciences & Biomedicine
(76)
Medicine
(43)
Humans
(42)
Medicine & Public Health
(42)
Female
(28)
Rheumatology
(28)
Male
(24)
Aged
(22)
Original Article
(21)
Rheumatoid Arthritis
(21)
Middle Aged
(19)
Adult
(15)
Patients
(15)
Treatment Outcome
(12)
Oncology
(11)
Cardiac & Cardiovascular Systems
(10)
Cardiovascular System & Cardiology
(10)
Drug Therapy
(10)
Arthritis, Rheumatoid - Drug Therapy
(8)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

7 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Drug tolerability and reasons for discontinuation of seven biologics in 4466 treatment courses of rheumatoid arthritis-the ANSWER cohort study

Management and treatment outcomes of rheumatoid arthritis in the era of biologic and targeted synthetic therapies: evaluation of 10-year data from the KURAMA cohort

Monocyte-derived transcriptomes explain the ineffectiveness of abatacept in rheumatoid arthritis

Drug retention of 7 biologics and tofacitinib in biologics-naïve and biologics-switched patients with rheumatoid arthritis: the ANSWER cohort study

Comparison of the drug retention and reasons for discontinuation of tumor necrosis factor inhibitors and interleukin-6 inhibitors in Japanese patients with elderly-onset rheumatoid arthritis-the ANSWER cohort study

Identification of anti-citrullinated osteopontin antibodies and increased inflammatory response by enhancement of osteopontin binding to fibroblast-like synoviocytes in rheumatoid arthritis

Efficacy of personalized exercise program on physical function in elderly patients with rheumatoid arthritis at high risk for sarcopenia: study protocol for a randomized controlled trial

N-terminus of Etanercept is Proteolytically Processed by Dipeptidyl Peptidase-4

Drug retention of sarilumab, baricitinib, and tofacitinib in patients with rheumatoid arthritis: the ANSWER cohort study

Comparison of efficacy between anti-IL-6 receptor antibody and other biological disease-modifying antirheumatic drugs in the patients with rheumatoid arthritis who have knee joint involvement: the ANSWER cohort, retrospective study

Drug retention of secondary biologics or JAK inhibitors after tocilizumab or abatacept failure as first biologics in patients with rheumatoid arthritis -the ANSWER cohort study

The real-world effectiveness of anti-RANKL antibody denosumab on the clinical fracture prevention in patients with rheumatoid arthritis: The ANSWER cohort study

Comparison of the efficacy and safety of biologic agents between elderly-onset and young-onset RA patients: the ANSWER cohort study

Large vessel vasculopathy in a patient with systemic lupus erythematosus: a case report

Correction to: Drug tolerability and reasons for discontinuation of seven biologics in 4466 treatment courses of rheumatoid arthritis-the ANSWER cohort study

The family history of rheumatoid arthritis in anti-cyclic citrullinated peptide antibody-positive patient is not a predictor of poor clinical presentation and treatment response with modern classification criteria and treatment strategy: the ANSWER cohort study

Late-onset rheumatoid arthritis registry study, LORIS study: study protocol and design

Mycophenolate mofetil versus intravenous cyclophosphamide for induction treatment of proliferative lupus nephritis in a Japanese population: a retrospective study

Comparative effectiveness of trimethoprim-sulfamethoxazole versus atovaquone for the prophylaxis of pneumocystis pneumonia in patients with connective tissue diseases receiving prolonged high-dose glucocorticoids

Mycophenolate mofetil versus intravenous cyclophosphamide for induction treatment of proliferative lupus nephritis in a Japanese population: a retrospective study

Comparison of safety and effectiveness between etanercept biosimilar LBEC0101 and reference in patients with rheumatoid arthritis in real-world data using the KURAMA cohort

Pathogenicity of IgG-Fc desialylation and its association with Th17 cells in an animal model of systemic lupus erythematosus

Enteric Toll-like receptor 7 stimulation causes acute exacerbation in lupus-susceptible mice

High plasma homocysteine level is associated with increased prevalence of the non-remission state in rheumatoid arthritis: Findings from the KURAMA cohort

Factors associated with osteoporosis and fractures in patients with systemic lupus erythematosus: Kyoto Lupus Cohort

Aktive Filter

Suchergebnisse filtern